Marex Group listed on the Nasdaq for an initial offering price of 19 on April 25 last year, then doubled as they hit their all-time high of 40.05 in February. Now, Marex stock is Tuesday's selection for Investor's Business Daily's IBD 50 Stocks To Watch.
Marex is surging in a consolidation base with a buy point at that 40.05 level as shares have rebounded from their 50-day moving average. An earlier handle entry at 39.28 is also an option for a more aggressive entry with Marex stock.
But though the stock has weathered the market correction better than most others, general market weakness and ongoing tariff news can affect its recent performance.
Marex Stock: Relative Strength At A High
Marex's relative strength line is at a 52-week high, as seen in the blue dot on IBD MarketSurge. Shares are also in an early-stage base that can lead to higher gains after a breakout.
Shares soared on April 2 when the financial services company held its investor's day and released preliminary first-quarter results. At the midpoint of its ranges, the company sees sales increasing 25% year over year to $456.8 million with earnings up 32% or 91 cents a share.
Marex also announced that it had acquired brokerage firm, Aarna Capital.
The stock then came under pressure as President Donald Trump announced hefty tariffs on Thursday but found support at the 50-day moving average before rebounding. That shows strong outperformance as even the benchmark index, the S&P 500, plummeted below its key moving averages on the news.
Top Echelon In Rankings
Marex provides financial services for the energy, commodities and financial markets. Marex stock ranks third in the financial services-specialty group, according to IBD Stock Checkup. The group holds 32nd place among Investor's Business Daily's 197 industry groups.
Marex has a Composite Rating of 98 and a best-possible Earnings Per Share Rating of 99. The Relative Strength Rating of 98 is outstanding. Mutual funds own 72% of outstanding shares. However, the Accumulation/Distribution Rating sits at C+ on a scale of A to E. That shows that funds have been moderate buyers of the stock in the recent 13 weeks.
Analysts see profits rising in 2025 and 2026. In 2025, they see earnings growth of 10% to $3.42 per share and a 11% growth in 2026 with earnings of $3.81 per share. The Up/Down Volume Ratio of 1.2 also shows the stock has been in demand over the past 50 trading days.
Please follow VRamakrishnan on X/Twitter for more news on the stock market today.
